Author/Authors :
Kermansaravi, Mohammad Department of Surgery - Minimally Invasive Surgery Research Center - Division of Minimally Invasive and Bariatric Surgery, Rasool-e Akram Hospital - Iran University of Medical Sciences, Tehran, Iran , Davarpanah Jazi, Amir Hossein Department of Surgery - Minimally Invasive Surgery Research Center - Al Zahra Hospital - Isfahan University of Medical Sciences, Isfahan, Iran , Talebian, Pedram Department of Surgery - Minimally Invasive Surgery Research Center - Division of Minimally Invasive and Bariatric Surgery, Rasool-e Akram Hospital - Iran University of Medical Sciences, Tehran, Iran , Rokhgireh, Samaneh Endometriosis Research Center - Iran University of Medical Sciences, Tehran, Iran , Kabir, Ali Minimally Invasive Surgery Research Center - Iran University of Medical Sciences, Tehran, Iran , Pazouki, Abdolreza Department of Surgery - Minimally Invasive Surgery Research Center - Division of Minimally Invasive and Bariatric Surgery, Rasool-e Akram Hospital - Iran University of Medical Sciences, Tehran, Iran
Abstract :
Morbidity and mortality rates are increased due to obesity after organ transplantation; in this regards, bariatric surgery (BS) is believed
to be an effective treatment for posttransplant obese patients. Nevertheless, some studies are doubtful in terms of the effectiveness
of BS, the most suitable bariatric procedure, and management of immunosuppressant drugs in some kinds of organ transplants.
We evaluated nonsurgical therapies, weight reduction, adjustment of immunosuppressants, comorbidities, and the recommended
surgical procedures for posttransplant BS for different types of organ transplantations.
Keywords :
Bariatric surgery , gastric bypass , immunosuppression , organ transplant
